CATALYST PHARMACEUTICALS, INC. financial data

Symbol
CPRX on Nasdaq
Location
Coral Gables, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 616% % 33%
Quick Ratio 18% % -13%
Debt-to-equity 15% % -13%
Return On Equity 26% % 2.5%
Return On Assets 23% % 4.5%
Operating Margin 45% % 18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122,912,387 shares 3.1%
Common Stock, Shares, Outstanding 123,264,583 shares 3.4%
Entity Public Float $1,720,853,867 USD 28%
Common Stock, Value, Issued $123,000 USD 3.4%
Weighted Average Number of Shares Outstanding, Basic 122,600,730 shares 3.1%
Weighted Average Number of Shares Outstanding, Diluted 127,090,194 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $578,196,000 USD 26%
Research and Development Expense $14,700,000 USD 36%
General and Administrative Expense $56,095,000 USD 0.3%
Operating Income (Loss) $258,775,000 USD 49%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $285,795,000 USD 51%
Income Tax Expense (Benefit) $68,231,000 USD 48%
Net Income (Loss) Attributable to Parent $217,564,000 USD 52%
Earnings Per Share, Basic 1 USD/shares 44%
Earnings Per Share, Diluted 1 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $689,892,000 USD 56%
Accounts Receivable, after Allowance for Credit Loss, Current $106,409,000 USD 83%
Inventory, Net $28,029,000 USD 40%
Assets, Current $852,453,000 USD 58%
Deferred Income Tax Assets, Net $48,256,000 USD -0.45%
Property, Plant and Equipment, Net $1,077,000 USD -22%
Operating Lease, Right-of-Use Asset $2,010,000 USD -13%
Assets $1,051,602,000 USD 36%
Accounts Payable, Current $9,096,000 USD -21%
Employee-related Liabilities, Current $10,573,000 USD 32%
Accrued Liabilities, Current $119,639,000 USD 28%
Liabilities, Current $128,735,000 USD 22%
Operating Lease, Liability, Noncurrent $2,461,000 USD -15%
Other Liabilities, Noncurrent $161,000 USD -94%
Liabilities $131,357,000 USD 18%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $446,789,000 USD 95%
Stockholders' Equity Attributable to Parent $920,245,000 USD 39%
Liabilities and Equity $1,051,602,000 USD 36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $60,043,000 USD 88%
Net Cash Provided by (Used in) Financing Activities $3,060,000 USD -98%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 123,264,583 shares 3.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $689,892,000 USD 56%
Interest Paid, Excluding Capitalized Interest, Operating Activities $103,000 USD 58%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $49,058,000 USD 28%
Operating Lease, Liability $2,889,000 USD -12%
Depreciation $115,000 USD 34%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $217,564,000 USD 52%
Lessee, Operating Lease, Liability, to be Paid $3,285,000 USD -14%
Operating Lease, Liability, Current $428,000 USD 8.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $570,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $553,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $396,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three $587,000 USD 3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $605,000 USD 3.1%
Operating Lease, Payments $132,000 USD 2.3%
Additional Paid in Capital $473,333,000 USD 9.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $9,345,000 USD 0.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%